Iohexol Injectable Solution Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 240 mg/mL, 300 mg/mL, 350 mg/mL, 140 mg/mL

Reference Brands: Omnipaque(US & EU)

Category: Contrast Agent

Iohexol Injectable Solution is available in Injectable Solution and strengths such as 240 mg/mL, 300 mg/mL, 350 mg/mL, 140 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Iohexol Injectable Solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Iohexol Injectable Solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Iohexol injectable solution, marketed as Omnipaque, is approved in the US by the FDA and in the EU via EMA for use as a contrast agent in diagnostic imaging. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety, efficacy, and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and broad global availability, enabling precise imaging for effective diagnosis and treatment planning worldwide.